Home - Products - Angiogenesis - EGFR - 7,8-Dihydroxyflavone

7,8-Dihydroxyflavone

CAS No. 38183-03-8

7,8-Dihydroxyflavone( 7,8-Dihydroxyflavone | DHF )

Catalog No. M18494 CAS No. 38183-03-8

7, 8-Dihydroxyflavone (7, 8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	51	In Stock
10MG	29	In Stock
50MG	63	In Stock
100MG	84	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

7,8-Dihydroxyflavone
Note

Research use only, not for human use.
Brief Description

7, 8-Dihydroxyflavone (7, 8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.
Description

7,8-Dihydroxyflavone is an agonist of tyrosine receptor kinase B (TrkB). It acts by promoting immature neuron survival after TBI through activation of the BDNF signaling pathway.
In Vitro

——
In Vivo

——
Synonyms

7,8-Dihydroxyflavone | DHF
Pathway

Angiogenesis
Target

EGFR
Recptor

TrkB
Research Area

Metabolic Disease|Neurological Disease
Indication

——

Chemical Information

CAS Number

38183-03-8
Formula Weight

254.24
Molecular Formula

C15H10O4
Purity

>98% (HPLC)
Solubility

DMSO : ≥ 100 mg/mL; 393.33 mM
SMILES

c1ccc(cc1)c1cc(=O)c2c(o1)c(c(cc2)O)O
Chemical Name

7,8-Dihydroxy-2-phenyl-chromen-4-one

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Lee RH, et al. Oncol Rep. 2015 Feb;33(2):631-8.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Tiotropium Bromide h...

Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.
Varlitinib

Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM respectively. Phase 2.
E4CPG

E4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.

Sign In Join Free